SOURCE: DARA BioSciences, Inc

DARA BioSciences, Inc

April 05, 2011 11:00 ET

DARA Biosciences, Inc. to Present at Taglich Brothers 8th Annual Small Cap Equity Conference

NEW YORK, NY--(Marketwire - April 5, 2011) - Taglich Brothers, Inc. is pleased to announce that Richard Franco, President & CEO of DARA BioSciences, Inc. (NASDAQ: DARA) will be presenting at our 8th Annual Small Cap Equity Conference May 3rd, 2011. The Conference will take place at the New York Athletic Club, New York City. To request additional information or to register, contact Taglich Brothers at 212-779-2971 or visit www.taglich.com.

About Taglich Brothers

Taglich Brothers, Inc. is a full-service broker dealer focused exclusively on microcap companies. The Company defines the microcap segment of the equity market as companies with less than $250 million in market capitalization. Taglich Brothers currently offers institutional and retail brokerage services, investment banking and comprehensive research coverage to the investment community.

About DARA BioSciences, Inc.

DARA BioSciences, Inc. is a North Carolina based biopharmaceutical development company that acquires promising therapeutic candidates and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies. Presently DARA has two drug candidates with cleared IND (Investigational New Drug) Applications from the United States FDA advancing through clinical development: 1. KRN5500 for the treatment of neuropathic pain; and 2. DB959 for the treatment of type 2 diabetes. In addition, the Company has a pipeline of diverse drug candidates at various stages of development, with 88 US and foreign granted patents and 60 pending applications. DARA owns CPT-1 inhibitors intended for topical application for patients with psoriasis, a library of DDPIV inhibitors and a diverse library of approximately 1800 PPAR agonists of various molecular modalities.

Contact Information

  • Contact:
    Taglich Brothers
    Karen Payne
    Symposia Events
    212-779-2971